Results 41 to 50 of about 49,423 (253)

Improvement of atopic dermatitis and alopecia universalis with dupilumab: a case report

open access: yesDermatology Reports, 2021
Dupilumab is an interleukin (IL)-4 receptor alpha antagonist that showed significant improvement of atopic dermatitis (AD). Many reports have shown significant resolution of alopecia areata, alopecia universalis, and alopecia totalis after dupilumab ...
Lama Alotaibi   +3 more
doaj   +1 more source

Modified platelet rich plasma therapy for alopecia totalis.

open access: yesJ Cutan Aesthet Surg, 2023
Alopecia areata (AA) is an autoimmune disease characterized most commonly by patchy nonscarring hair loss which may progress to alopecia totalis which has poor prognosis. Platelet-rich plasma (PRP) therapy along with intralesional triamcinolone acetonide
Dhiman A, Bagri M.
europepmc   +2 more sources

Hydroxychloroquine for granuloma annulare: A case report on secondary hair growth in alopecia universalis

open access: yesSAGE Open Medical Case Reports, 2023
Alopecia areata is an autoimmune disease resulting in non-scarring hair loss. Alopecia areata can progress to become alopecia totalis (loss of hair from the entire scalp) or alopecia universalis (loss of hair form the entire body), with the progression ...
Selena Osman, Danya Traboulsi
doaj   +1 more source

Seasonal patterns in alopecia areata, totalis, and universalis [PDF]

open access: bronzeJournal of the American Academy of Dermatology, 2018
Elana Putterman, Leslie Castelo‐Soccio
openalex   +3 more sources

A Case of Azathioprine Induced Severe Myelosuppression and Alopecia Totalis in IgA Nephropathy [PDF]

open access: yesChildhood Kidney Diseases, 2017
Azathioprine is commonly used as immunosuppressive therapy for various inflammatory diseases including chronic glomerulonephritis. Myelosuppression is a common side effect of azathioprine, resulting in the need for dose reduction.
Jae Choon Kim   +6 more
doaj   +1 more source

Progress in immune pathogenesis and targeted therapy of alopecia areata

open access: yesPifu-xingbing zhenliaoxue zazhi, 2023
Alopecia areata is a common clinical non-cicatricial alopecia. Alopecia totalis and generalized alopecia may occur in severe cases. The pathogenesis of alopecia areata is complex, and the treatment is faced with many difficulties.
Jiali WANG   +3 more
doaj   +1 more source

Alopecia totalis sparing congenital melanocytic nevus: Renbök phenomenon

open access: goldDermatologica Sinica, 2019
Toshiyuki Yamamoto   +2 more
doaj   +2 more sources

Alopecia areata. Diagnostic and therapeutic recommendations of the Polish Dermatological Society. Part 1. Diagnosis and severity assessment

open access: yesPrzegląd Dermatologiczny, 2023
The existence of two types of alopecia areata is suggested (probably genetically different): early-onset, with more severe symptoms, longer disease duration, higher tendency to relapse, often with a positive family history, and late-onset, in which the ...
Adriana Rakowska   +8 more
doaj   +1 more source

A patient with rickets and alopecia totalis

open access: yesThe Journal of Clinical and Scientific Research, 2023
Rickets is a disorder of bone mineralisation. Common causes of rickets are dietary calcium and Vitamin deficiency. Mutations in vitamin D activity are known to cause Vitamin D-resistant rickets (VDRRs).
Shanthisree Edara   +5 more
semanticscholar   +1 more source

Efficacy of Trichloroacetic Acid in Patients with Alopecia Areata: A Clinico-Histopathological Study [PDF]

open access: yesInternational Journal of Medical Arts, 2023
Background: Alopecia areata is an autoimmune disorder caused by a breakdown in the follicular immune privilege system, resulting in non-scarring hair loss. Many therapeutic options have been tested with variable results.
Hossam Anter   +3 more
doaj   +1 more source

Home - About - Disclaimer - Privacy